Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Isabella VisuriCarl ErikssonSara KarlqvistByron LykiardopoulosPer KarlénOlof GripCharlotte SödermanSven AlmerErik HertervigJan MarsalCarolina MalmgrenJenny DelinHans StridMats SjöbergDaniel BergemalmHenrik HjortswangJonas HalfvarsonPublished in: Therapeutic advances in gastroenterology (2023)
ENCePP registration number: EUPAS22735.